Showing 1 - 2 results of 2 for search 'J. D. Soumerai', query time: 0.02s
Refine Results
-
1
P687: A PHASE 1 STUDY WITH THE NOVEL B-CELL LYMPHOMA 2 (BCL2) INHIBITOR BGB-11417 AS MONOTHERAPY OR IN COMBINATION WITH ZANUBRUTINIB (ZANU) IN PATIENTS (PTS) WITH B-CELL MALIGNANCI... by S. Opat, C. Y. Cheah, M. Lasica, E. Verner, P. J. Browett, H. Chan, J. D. Soumerai, E. González Barca, J. Hilger, Y. Fang, J. Huang, D. Simpson, C. S. Tam
Published 2022-06-01
Article -
2
P1114: ZANDELISIB ON INTERMITTENT DOSING AS A SINGLE AGENT OR IN COMBINATION WITH RITUXIMAB OR ZANUBRUTINIB IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): RESULTS FROM A MU... by J. D. Soumerai, D. Jagadeesh, H. Salman, F. Samaniego, K. Patel, A. Stathis, N. Reddy, V. P. Kenkre, A. Asch, C. Diefenbach, I. S. Lossos, D. Persky, F. Awan, W. Huang, K. Vandever, A. D. Zelenetz
Published 2022-06-01
Article